| Effect | None |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 31 |
| Gender | Female |
| Age Range | 18-29, 30-44 |
| Body Types | Average |
Oral supplementation of 80mg Promensil for three menstrual cycles in otherwise healthy women failed to significantly alter any biomarker of glucose or lipid metabolism measured despite urinary isoflavones increasing 15-fold.
